🔎 Trials Near Me

Akèy › Kansè vejik › Illinois › Cicero

Etid klinik pou Kansè vejik nan Cicero, IL

8 etid pou Kansè vejik ap chèche patisipan nan sit nan ak bò kote Cicero (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

Ap rekriteFaz 3
  • Loyola University Medical Center, Maywood · 5 mi lwen
  • Marjorie Weinberg Cancer Center at Loyola-Gottlieb, Melrose Park · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07000084

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • OSF Little Company of Mary Medical Center, Evergreen Park · 9 mi lwen
  • Advocate Christ Medical Center, Oak Lawn · 9 mi lwen
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

Ap rekriteFaz 2
  • Associated Urological Specialists - Chicago Ridge ( Site 0139), Chicago Ridge · 10 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06833073

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

Ap rekriteFaz 2
  • Northwestern Medicine Oak Brook, Oak Brook · 9 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07061964

Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)

Ap rekriteFaz 3
  • Hope and Healing Clinical Research LLC, Hinsdale · 10 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07566156

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Ap rekriteFaz 2
  • Loyola University Medical Center, Maywood · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT03866382

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

Ap rekriteFaz 2
  • Associated Urological Specialists, Chicago Ridge · 10 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT06567743

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

Ap rekriteFaz 3
  • Rush MD Anderson Cancer Center at Rush Oak Park, Oak Park · 3 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT07097142

Etid Kansè vejik nan lòt vil

Lòt etid nan Cicero

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.